{
  "title": "What this review means",
  "includeSubclaimIllustrations": false,
  "redteamReviewed": true,
  "accessNotice": "Source checking used bounded original primary abstract passages/status records and selected original partial-body passages. No complete-abstract or complete-paper audit, or independent scientific peer review, is claimed. Detailed access counts and limitations appear in the review.",
  "overview": "Pasteurized MucT reduced weight regain in a 2026 trial; broader clinical glycemic benefits and interchangeability with other products remain unestablished.",
  "implications": "The original preregistered primary SC2 returns Γ, with Moderate appraisal confidence, because target/insulin-sensitivity effects do not establish the registered clinical glycemia/function benefit. The positive 2026 randomized weight-maintenance finding is separately scored Δ in supplemental SC5. No positive trial is discarded, and no generic class or all-metabolic-benefits negative conclusion is inferred.",
  "limitations": "59 primary reports with 2 selected partial-body examinations; evidence density, heterogeneous controls and reproducibility set the confidence, not correctness or access depth. The grade applies to the exact registered claim; stronger findings for narrower subclaims remain separate. No complete-paper audit or blinded calibration is claimed. This educational review does not establish an individual treatment recommendation."
}